Physicochemical Properties
| Molecular Formula | C18H23F3N2O5 |
| Molecular Weight | 404.380835771561 |
| Exact Mass | 404.155 |
| CAS # | 1336913-03-1 |
| PubChem CID | 134812840 |
| Appearance | Off-white to light yellow solid powder |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 28 |
| Complexity | 452 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | C(F)(F)(F)C(=O)O.N([C@@H]1CN2CCC1CC2)C(C1C=C(OC)C=CC=1OC)=O |
| InChi Key | GLKCNNXBIUCCJJ-PFEQFJNWSA-N |
| InChi Code | InChI=1S/C16H22N2O3.C2HF3O2/c1-20-12-3-4-15(21-2)13(9-12)16(19)17-14-10-18-7-5-11(14)6-8-18;3-2(4,5)1(6)7/h3-4,9,11,14H,5-8,10H2,1-2H3,(H,17,19);(H,6,7)/t14-;/m1./s1 |
| Chemical Name | N-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,5-dimethoxybenzamide;2,2,2-trifluoroacetic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | PSEM 89S (10 or 30μM) stimulates layer 2/3 cortical neurons that express PSAML141F,Y115F-5HT3 high conductance (HC) (Pharmacologically Selective Actuator Module)[1]. Transfected neurons were reversibly silenced by PSEM 89S (10 μM) through a reduction in cellular input resistance [1]. |
| ln Vivo | In mice expressing PSAML141F,Y115F-glycine receptor (GlyR) (30 mg/kg), PSEM 89S significantly lowers photostimulation-evoked eating; however, this effect is not observed in mice expressing just channelrhodopsin-2 (ChR2) (50 mg/kg)[1]. 30 mg/kg exhibits good brain penetration in mice following intraperitoneal treatment in a less invasive manner[1]. |
| Animal Protocol |
Animal/Disease Models: Male Agrp-cre mice (3-6 weeks)[1] Doses: 30 mg/kg Route of Administration: Ip administration Experimental Results: Almost completely suppressed fos (a marker of neuron activation) in ChR2-expressing neurons. Animal/Disease Models: C57BL/6 mice[1] Doses: 30 mg/kg (pharmacokinetic/PK Analysis) Route of Administration: Ip administration Experimental Results: Rised rapidly in serum and brain, and was mostly cleared from both compartments in 1 h. |
| References |
[1]. Chemical and genetic engineering of selective ion channel-ligand interactions. Science. 2011 Sep 2; 333(6047): 1292-6. |
Solubility Data
| Solubility (In Vitro) |
DMSO: 100 mg/mL (247.29 mM) H2O: ≥ 100 mg/mL (247.29 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.18 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.18 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (6.18 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4729 mL | 12.3646 mL | 24.7292 mL | |
| 5 mM | 0.4946 mL | 2.4729 mL | 4.9458 mL | |
| 10 mM | 0.2473 mL | 1.2365 mL | 2.4729 mL |